腹部外科常见感染性疾病的病原菌及药敏试验研究

为了了解本地区本医院腹部外科感染性疾病病原菌的构成比和药物敏感率的变化,指导临床用药,我们采用美国BD公司生产的6B和7D两种增菌瓶采集标本和培养细菌,并用该公司生产的生化板和药敏板,对1994～1996年269例常见的普外科感染性疾病患者的手术标本进行前瞻性的细菌培养和药敏试验研究.     

Effect of Ca2+-homopantothenate and mild hypoxia on some enzyme activities evaluated in subcellular fractions from different rat brain regions

The effect of Ca²⁺-homopantothenate (HOPA) treatment (250 mg/kg for 5 d) has been studied by evaluating the specific activity of enzymes related to: glycolytic pathway (hexokinase, phosphofruc-tokinase, pyrurate kinase, lactate dehydrogenase), tricarboxylic acid cycle (citrate synthase, malate dehydrogenase), mitochondrial electron transfer chain (succinate dehydrogenase, cytochrome oxidase), NADH redox state (NADH cytochromec reductase), acetylcholine metabolism (acetylcholinesterase), and glutamate metabolism (glutamate dehydrogenase). The enzymatic activity assays were performed on homogenatein toto, nonsynaptic mitochondria and synaptosomes isolated from: cerebral cortex, hippocampus, striatum, hypothalamus, medulla oblongata, and cerebellum of normoxic rats and rats submitted to intermittent normobaric hypoxia (90:10, N₂:O₂). In normoxic rats, HOPA was unable to induce any modification. Hypoxiaper se induced a decrease in the activity of synaptosomal cytochrome oxidase in cerebral cortex, hippocampus, and cerebellum.     

Prevalence of yersinia antibodies in blood donors

Agglutinins titers against Y. enterocolitica 0:3, 0:5, 0:9 and Y. pseudotuberculosis I were determined by the microagglutination method in 777 blood donor sera.Titers of <- 1/10 were observed in 93.5% of the subjects for Y. enterocolitica 0:3, in 87.8% for Y. enterocolitica 0:9 and in 95.1% for Y. enterocolitica 0:5 and for Y. pseudotuberculosis I. Low level titers (1/10 – 1/20) were found in 11.4% to 23.1%. Titers of 1/40 were observed in 1.7% for Y. enterocolitica 0:3, in 1.4% for Y. enterocolitica 0:5, in 5.1% for Y. enterocolitica 0:9 and in 1.2% for Y. pseudotuberculosis I. Titers of 1/80 were seen in 0.2% for Y. enterocolitica 0:3, in 0.1% for Y. enterocolitica 0:5 and in 1.3% for Y. enterocolitica 0:9. Only in one donor's serum was a titer of 1/160 against Y. enterocolitica 0:9 found.The upper limit of normal titer at 15% cutoff level against Yersinia antigens, found in blood donor sera by the microagglutination test, was 1/10.     

Phase i/ii trial of 5-Fluorouracil, leucovorin, Zidovudine and dipyridamole for patients with metastatic colorectal-cancer, renal-cell carcinoma and malignant-melanoma

We conducted a phase I/II trial of 5-fluorouracil (5-FU), calcium leucovorin (LV), zidovudine (AZT) and dipyridamole (DP), (FLAP) in patients with metastatic colorectal cancer, renal cell carcinoma and malignant melanoma. AZT and DP were given to enhance the biochemical modulation and antitumor activity of 5-FU and LV. All patients received 5-FU (370 mg/m(2) i.v. bolus day 0-4), LV (50 mg/m(2) p.o. every 4 h day 0-4) and DP (50 mg/m(2) p.o. every 6 h days 0-27). In the phase I portion of the study, AZT was dose escalated in cohorts of 5 patients each, from 50 mg p.o. every 6 h days 0-27 to the MTD of 200 mg p.o. every 6 h days 0-27. Thirty-three patients received 200 mg of AZT in the phase II portion of the trial. Eleven patients developed grade III and 5 patients developed grade IV leukopenia. Four patients developed grade III and 21 patients developed grade IV neutropenia, with six febrile neutropenic episodes. Six patients experienced grade III anemia and four grade III thrombocytopenia. Diarrhea or stomatitis of greater than or equal to grade III occurred in six and four patients, respectively. Fifty-eight percent (19 of 33) of patients required dose reductions of AZT for hematologic toxicity (13 of 19 in the first treatment cycle). At the 200 mg AZT dose level, there were two partial responses in nine colorectal cancer patients (22%), no objective responses in 14 patients with renal cell carcinoma or in 14 patients with melanoma. FLAP does not have significant activity in melanoma, renal cell carcinoma or 5-FU-treated colorectal cancer patients, although it may have activity in untreated colon cancer.     

Multidisciplinary approach to palliation of obstructive jaundice caused by a central hepatocellular carcinoma

BACKGROUND/AIMS: Obstructive jaundice due to intraductal tumour growth is a rare symptom in association with hepatocellular carcinoma (HCC). METHODS: We report a 65-year-old white male who was admitted to our department with a 2-week history of progressive jaundice. At laparotomy, the liver showed advanced cirrhosis due to long-standing biliary obstruction. Cholangiography confirmed total obstruction of the main bifurcation of the hepatic duct by intraductal tumour growth. Combination treatment with surgical segment III drainage, transcatheter arterial embolization and radioembolization with yttrium-90 resin particles and endoscopic stenting was performed. This form of treatment has never been reported before. RESULTS: With these combined procedures, relief of jaundice and a survival time of 32 months could be achieved. CONCLUSION: The combination of palliative methods may relieve jaundice, ensure a good quality of life and possibly prolong survival in patients with mechanical tumour obstruction of the biliary tree by HCC.     

Diagnosis of pulmonary embolism: Ventilation perfusion scintigraphy versus helical computed tomography pulmonary angiography

The present study compared the accuracy of ventilation perfusion scintigraphy (VQS) and CT pulmonary angiography (CTPA) for the diagnosis of pulmonary embolism. This was a prospective observational study of 112 patients with suspected pulmonary embolism (PE) who could be studied with both investigations within 24 h. Results were compared to final diagnosis at completion of 6-month follow up, using receiver operating characteristic (ROC) analysis. Pulmonary embolism was diagnosed in 27 referred patients (24%). The sensitivity and specificity of VQS and CTPA were similar to that reported from the literature. A normal VQ scan had the highest negative predictive value (100%), while a high-probability VQ scan had the highest positive predictive value (92%). There was no overall difference (area under the ROC curve (AUC)) between VQS (AUC (95% CI) = 0.82 (0.75,0.89)) and CTPA (AUC = 0.88 (0.81,0.94)) for the diagnosis of PE. Among patients with abnormal chest X-rays, CTPA (AUC 0.90 (0.83,0.97)) appeared somewhat better than VQS (AUC 0.78 (0.68,0.88)) but this difference did not reach statistical significance. In this instance, CTPA is at least as accurate as VQS and may provide an opportunity to make alternative diagnoses.     

Morpho-structural aspects of Er:YAG-prepared class V cavities

OBJECTIVE: The aim of this study was to evaluate the ability of an Er:YAG laser (2960nm) to prepare class V cavities as compared with rotary instruments. MATERIALS AND METHODS: Twenty-six freshly extracted human molars were selected and randomly distributed in two groups. Non standardized class V cavities were prepared using (group 1) a diamond bur for enamel, plus a tungsten bur for dentin with water irrigation and (group 2) an Er:YAG laser (output parameters, enamel: 1000 mJ, 12Hz, dentin: 500 mJ, 20Hz) with a continuous flow of water. RESULTS: The SEM examination revealed characteristic micro-irregularities of the lased samples as compared with the conventional prepared cavities: group 1, the walls of the cavities were slightly curved and a smear layer plus muds covered peripheric walls as well as the depth of the cavity; rare dentinal tubules were opened; linear and circular surface irregularities were observed on the dentin; and group 2, the walls of the cavities were irregular, jagged; photo-ablation creates a real cleavage of hydroxyapatite prisms with respect to the enamel prism pathway; an homogeneous dentin with opened dentinal tubules covered the depth of the cavities; intertubular dentin is selectively more ablated than Er-YAG the peritubular dentin. CONCLUSIONS: Jagged outline as well as opened dentinal tubules are the main characteristics of the Er-YAG prepared class V cavities. Further investigations (ulstrastructural, histochemical properties of the lased dentin, resistance to traction of bonded resins) should be conducted.     

Pain management in ambulatory surgery.

Successful ambulatory surgery is dependent on analgesia that is effective, has minimal adverse effects, and can be safely managed by the patient at home after discharge. A number of studies have identified that the provision of effective postoperative analgesia is inadequate for a significant proportion of patients. The following discussion details the current available analgesic options for ambulatory surgery patients and the rationale for their use. Preemptive analgesia should be given to all patients unless there are specific contraindications. Consideration should be given to the use of long-acting oral COX-2 selective nonsteroidal anti-inflammatory drugs (NSAIDs) and long-acting oral opioids to treat postoperative pain. A standardized multimodal postdischarge analgesic regimen tailored to the patient's expected postoperative pain levels should be prescribed. Patient follow-up by telephone questionnaire will confirm those surgical procedures that result in mild or moderate-to-severe postoperative pain and the effectiveness of treatment plans.